GENEWIZ provides extraction, library preparation, sequencing, and bioinformatics support for genomic research.
Competing Products
Azenta
Leading life science solutions provider enabling faster breakthroughs and therapies worldwide.
Founded
1994Leading life science solutions provider enabling faster breakthroughs and therapies worldwide.
Azenta, Inc., formerly known as Brooks Automation, was founded in 1978 and is headquartered in Burlington, Massachusetts. The company's core mission is to accelerate scientific breakthroughs and therapies worldwide. Azenta provides comprehensive life sciences solutions, including cold-chain sample management and genomic services, catering to pharmaceutical, biotech, academic, and healthcare institutions globally. Their offerings support critical areas such as drug development, clinical research, and advanced cell therapies.
Notable figures associated with Azenta include CEO Stephen S. Schwartz and CFO Lindon G. Robertson. The company is publicly traded on Nasdaq under the ticker AZTA and is a component of the S&P 400. With a revenue of $879 million in 2020, Azenta has made significant strides in the biotechnology industry. Despite an operating loss in 2022, the company reported a net income of over $2 billion, reflecting its impactful presence in the life sciences sector.
Companies similar to Azenta include Thermo Fisher Scientific, Lonza, Bio-Rad and Catalent.
Azenta was founded in 1994.
Azenta's headquarters is located in Burlington, MA, US.
Azenta's most recent funding round was for $500M (USD) in November 2022.
As of Nov 23, 2022, Azenta has disclosed funding of $508.3M (USD). Undisclosed round amounts are excluded.
Azenta has 3,200 employees as of Feb 6, 2024.
Catalent
catalent.com